Li Yukun, Mao Tianhao, Zheng Liwei, Zhou Zhao, Jiang Qianqian, Du Xinyu, Ma Ziyuan, Liu Xin, Zhang Ting, Wei Guochao, Wang Lin, Liu Yongzhen, Zhang Xiaojing, Liu Shourong, Chen Xiangmei, Lu Fengmin
Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, 100044, China.
Virol Sin. 2025 Jun;40(3):374-387. doi: 10.1016/j.virs.2025.05.004. Epub 2025 May 22.
The persistence of covalently closed circular DNA (cccDNA) in hepatitis B virus (HBV)-infected hepatocytes remains a major obstacle to effective antiviral treatment. Understanding the molecular mechanisms regulating HBV cccDNA transcription is essential for developing novel therapeutic strategies. In this study, we investigated the role of RNA binding motif protein 25 (RBM25) in HBV replication, focusing on its interaction with cccDNA and its regulation of host transcription factors. The results demonstrated that RBM25 knockdown markedly inhibited HBV replication, reducing levels of HBV DNA, hepatitis B e antigen (HBeAg), hepatitis B surface antigen (HBsAg), HBV RNA, and L-HBs in HBV-replicating and infected cell models. Consistent results were observed in a mouse model hydrodynamically injected with 1.2 × HBV plasmid. Conversely, RBM25 overexpression significantly enhanced HBV replication. Mechanistically, RBM25 promoted HBV promoter activities by binding to cccDNA through its RE/RD and PWI domains. This effect was mediated by increased Yin Yang 1 (YY1) expression, which enhanced acetylation of cccDNA-bound histones, promoting HBV transcription. Furthermore, RBM25 expression was upregulated and translocated to the nucleus following core protein expression and accumulation, while overexpression of RBM25 promoted core protein degradation. In conclusion, this study demonstrates that RBM25 is a novel host factor that enhances HBV replication by upregulating YY1-dependent transcriptional activation of cccDNA. It also reveales a reciprocal regulatory mechanism between the HBV core protein and RBM25, which helps sustain HBV replication.
共价闭合环状DNA(cccDNA)在乙型肝炎病毒(HBV)感染的肝细胞中的持续存在仍然是有效抗病毒治疗的主要障碍。了解调节HBV cccDNA转录的分子机制对于开发新的治疗策略至关重要。在本研究中,我们研究了RNA结合基序蛋白25(RBM25)在HBV复制中的作用,重点关注其与cccDNA的相互作用及其对宿主转录因子的调节。结果表明,在HBV复制和感染的细胞模型中,敲低RBM25可显著抑制HBV复制,降低HBV DNA、乙型肝炎e抗原(HBeAg)、乙型肝炎表面抗原(HBsAg)、HBV RNA和L-HBs的水平。在经尾静脉高压注射1.2×HBV质粒的小鼠模型中也观察到了一致的结果。相反,过表达RBM25可显著增强HBV复制。机制上,RBM25通过其RE/RD和PWI结构域与cccDNA结合,促进HBV启动子活性。这种作用是由阴阳1(YY1)表达增加介导的,YY1增强了与cccDNA结合的组蛋白的乙酰化,促进了HBV转录。此外,RBM25的表达在核心蛋白表达和积累后上调并转移至细胞核,而过表达RBM25则促进核心蛋白降解。总之,本研究表明RBM25是一种新型宿主因子,通过上调依赖YY1的cccDNA转录激活来增强HBV复制。它还揭示了HBV核心蛋白与RBM25之间的相互调节机制,这有助于维持HBV复制。